Research has confirmed that the GM and its metabolites can mitigate acetaminophen overdose-induced DILI [61]
3,4 American Association of Clinical Endocrinology guidelines recommend treatment with GLP-1RA in T2DM patients with coexisting ASCVD, high-risk for ASCVD, heart failure, or chronic kidney disease regardless of their glycemic control due to their organ protective effects
21, 2025, and has been updated with more recent valuation data, information about the pricing landscape following most-favored nation pricing negotiations, and details on Pfizers deal to buy clinical-stage biotech company Metsera
What is the clinical difference between sublingual and injectable tirzepatide
One of these SCFAs is called butyrate, and butyrate raises GLP-1